scholarly journals Cervical cancer screening: a prospective cohort study of the effects of historical patient compliance and a population‐based informatics prompted reminder on screening rates

2013 ◽  
Vol 20 (2) ◽  
pp. 136-143 ◽  
Author(s):  
Kathy L. MacLaughlin ◽  
Kristi M. Swanson ◽  
James M. Naessens ◽  
Kurt B. Angstman ◽  
Rajeev Chaudhry
Keyword(s):  
Cervical Cancer ◽  
Cohort Study ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Patient Compliance ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Population Based

scholarly journals Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study

BMJ Open ◽  
2016 ◽  
Vol 6 (8) ◽  
pp. e011981 ◽  
Author(s):  
Sveinung Wergeland Sørbye ◽  
Silje Fismen ◽  
Tore Jarl Gutteberg ◽  
Elin Synnøve Mortensen ◽  
Finn Egil Skjeldestad
Keyword(s):  
Cervical Cancer ◽  
Cohort Study ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Hpv Mrna ◽  
Primary Cervical Cancer Screening

scholarly journals Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study

2021 ◽  
Vol 13 ◽  
pp. 175883592110109
Author(s):  
Binhua Dong ◽  
Huachun Zou ◽  
Xiaodan Mao ◽  
Yingying Su ◽  
Hangjing Gao ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cohort Study ◽  
Human Papillomavirus ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Cox Regression ◽  
Intraepithelial Neoplasia ◽  
Population Based ◽  
Hpv Genotyping ◽  
Cytology Screening

Background: China’s Fujian Cervical Pilot Project (FCPP) transitioned cervical cancer screening from high-risk human papillomavirus (HR-HPV) nongenotyping to genotyping. We investigated the clinical impact of this introduction, comparing performance indicators between HR-HPV genotyping combined with cytology screening (HR-HPV genotyping period) and the previous HR-HPV nongenotyping combined with cytology screening (HR-HPV nongenotyping period). Methods: A retrospective population-based cohort study was performed using data from the FCPP for China. We obtained data for the HR-HPV nongenotyping period from 1 January 2012 to 31 December 2013, and for the HR-HPV genotyping period from 1 January 2014 to 31 December 2016. Propensity score matching was used to match women from the two periods. Multivariable Cox regression was used to assess factors associated with cervical intraepithelial neoplasia of grade 2 or worse (CIN2+). The primary outcome was the incidence of CIN2+ in women aged ⩾25 years. Performance was assessed and included consistency, reach, effectiveness, adoption, implementation and cost. Results: Compared with HR-HPV nongenotyping period, in the HR-HPV genotyping period, more CIN2+ cases were identified at the initial screening (3.06% versus 2.32%; p < 0.001); the rate of colposcopy referral was higher (10.87% versus 6.64%; p < 0.001); and the hazard ratio of CIN2+ diagnosis was 1.64 (95% confidence interval, 1.43–1.88; p < 0.001) after controlling for health insurance status and age. The total costs of the first round of screening (US$66,609 versus US$65,226; p = 0.293) were similar during the two periods. Higher screening coverage (25.95% versus 25.19%; p = 0.007), higher compliance with age recommendations (92.70% versus 91.69%; p = 0.001), lower over-screening (4.92% versus 10.15%; p < 0.001), and reduced unqualified samples (cytology: 1.48% versus 1.73%, p = 0.099; HR-HPV: 0.57% versus 1.34%, p < 0.001) were observed in the HR-HPV genotyping period. Conclusions: Introduction of an HR-HPV genotyping assay in China could detect more CIN2+ lesions at earlier stages and improve programmatic indicators. Evidence suggests that the introduction of HR-HPV genotyping is likely to accelerate the elimination of cervical cancer in China.

scholarly journals Psychiatric morbidity and cervical cancer screening: a retrospective population-based case–cohort study

CMAJ Open ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. E134-E141
Author(s):  
Michael Ouk ◽  
Jodi D. Edwards ◽  
Jessica Colby-Milley ◽  
Alexander Kiss ◽  
Walter Swardfager ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cohort Study ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Psychiatric Morbidity ◽  
Population Based

scholarly journals Cervical cancer screening uptake among HIV-positive women in Ontario, Canada: A population-based retrospective cohort study

2018 ◽  
Vol 107 ◽  
pp. 14-20 ◽  
Author(s):  
Ann N. Burchell ◽  
Claire E. Kendall ◽  
Stephanie Y. Cheng ◽  
Aisha Lofters ◽  
Michelle Cotterchio ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cohort Study ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Population Based ◽  
Hiv Positive ◽  
Screening Uptake ◽  
Hiv Positive Women

scholarly journals Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0135534 ◽  
Author(s):  
Ellinor Östensson ◽  
Susanna Alder ◽  
K. Miriam Elfström ◽  
Karin Sundström ◽  
Niklas Zethraeus ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cohort Study ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Population Based ◽  
Screening Population
Sign in / Sign up

Export Citation Format

Share Document